Medtech fundings for September 2015 have jumped off at a fast pace and now stand at $457 million, with fundings led by the $300 million IPO of NovoCore, followed by the $100 Series C for CeQur.
Below are the top fundings for the month thus far. Please revisit this post and refresh your browser to see additional fundings during the month.
Medtech fundings for September 2015 have jumped off at a fast pace and now stand at $457 million, with fundings led by the $300 million IPO of NovoCore, followed by the $100 Series C for CeQur.
Below are the top fundings for the month thus far. Please revisit this post and refresh your browser to see additional fundings during the month.
| COMPANY, FUNDING | PRODUCT/TECHNOLOGY |
|---|---|
| NovoCure has registered for a $300 million IPO, according to press reports | Tumor treating fields, employ low-intensity, alternating fields to treat cancer |
| CeQur Corp. has raised $100 million in a Series C round of funding according to the company | Insulin infusion device for type 2 diabetes |
| Ivenix, Inc., has raised $42 million in a round of funding according to the company | Infusion technologies |
For the complete list of medtech fundings in September 2015, see link.
For a historical list of the individual fundings in medtech, by month, since 2009, see link.
